1. Home
  2. STKL vs KALV Comparison

STKL vs KALV Comparison

Compare STKL & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SunOpta Inc.

STKL

SunOpta Inc.

N/A

Current Price

$6.46

Market Cap

768.0M

ML Signal

N/A

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

N/A

Current Price

$18.28

Market Cap

757.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
STKL
KALV
Founded
1973
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
768.0M
757.7M
IPO Year
1999
2014

Fundamental Metrics

Financial Performance
Metric
STKL
KALV
Price
$6.46
$18.28
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$7.83
$30.00
AVG Volume (30 Days)
2.8M
554.3K
Earning Date
04-13-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
186.67
N/A
EPS
0.13
N/A
Revenue
$817,715,000.00
$50,000,000.00
Revenue This Year
$13.82
N/A
Revenue Next Year
$6.95
N/A
P/E Ratio
$49.81
N/A
Revenue Growth
12.99
495.66
52 Week Low
$3.32
$9.83
52 Week High
$6.94
$19.00

Technical Indicators

Market Signals
Indicator
STKL
KALV
Relative Strength Index (RSI) 76.35 71.25
Support Level $5.73 $14.45
Resistance Level $6.53 $19.00
Average True Range (ATR) 0.05 0.72
MACD -0.07 0.23
Stochastic Oscillator 44.83 94.70

Price Performance

Historical Comparison
STKL
KALV

About STKL SunOpta Inc.

SunOpta Inc is a Canadian company that focuses on a healthy product portfolio. The company is a manufacturer for natural and private label brands and also produces its own propriety brands, including SOWN, Dream and West Life. The core of its product portfolio is a range of plant-based beverages, including oat, almond, soy, coconut and rice milks and creamers, which have a favorable climate profile relative to traditional dairy milks in terms of lower carbon emissions and water usage. Their plant-based offerings include non-genetically modified, organic, and gluten-free products. The consumer products portfolio also includes protein shakes, teas, broths, and fruit snacks. Geographically, the company operates in U.S, Canada and Others, out of which it derives maximum revenue from U.S.

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

Share on Social Networks: